Access cutting-edge ovarian cancer treatment through this clinical trial at a research site in Reno. Study-provided care at no cost to qualified participants.
Access ovarian cancer specialists in Reno at no cost
This study follows strict safety protocols and ethical guidelines
All study-related ovarian cancer treatment provided free
The purpose of this study is to evaluate the incidence rate and severity of prespecified mirvetuximab soravtansine (MIRV)-related ocular treatment-emergent adverse events (TEAEs) and assess prophylaxis strategies in all participants (symptomatic and asymptomatic) undergoing prospective ophthalmic evaluation with recurrent ovarian cancer (participants with either platinum-sensitive ovarian cancer \[PSOC\] or platinum-resistant ovarian cancer \[PROC\]) with high folate receptor alpha (FRα) express
Sponsor: AbbVie
Check if you qualify for this ovarian cancer clinical trial in Reno, NV
If you're searching for ovarian cancer treatment options in Reno, NV, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Reno research site is actively enrolling participants for this clinical trial. You'll receive care from experienced ovarian cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.